Investor Relations

SEC Filings

Document Details

Form
Filing Date
Dec 17, 2024
Document Date
Dec 14, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.